Neuroendocrine Tumor Treatment
4 mins read
Neuroendocrine Tumor Treatment Market SWOT analysis and Key Growth Methodologies By 2028 – Novartis AG, Boehringer Ingelheim International GmbH, Pfizer, Inc., psen Pharma, Amgen Inc., AVEO Pharmaceutical
The neuroendocrine tumor treatment market is expected to grow globally with an estimated healthy CAGR of 10.9% to reach USD 4.71 billion by 2028. The market is majorly driven increasing prevalence of neuroendocrine carcinoma, technological advancements, ongoing clinical, rising number of government initiatives. Neuroendocrine tumors are a rare kind of tumor. It is estimated […]